Display options
Cite
Wang S, Yang Y, Zhao Y, et al. Sub-MIC Tylosin Inhibits Streptococcus suis Biofilm Formation and Results in Differential Protein Expression. Front Microbiol. 2016;7:384doi: 10.3389/fmicb.2016.00384.
Wang, S., Yang, Y., Zhao, Y., Zhao, H., Bai, J., Chen, J., Zhou, Y., Wang, C., & Li, Y. (2016). Sub-MIC Tylosin Inhibits Streptococcus suis Biofilm Formation and Results in Differential Protein Expression. Frontiers in microbiology, 7384. https://doi.org/10.3389/fmicb.2016.00384
Wang, Shuai, et al. "Sub-MIC Tylosin Inhibits Streptococcus suis Biofilm Formation and Results in Differential Protein Expression." Frontiers in microbiology vol. 7 (2016): 384. doi: https://doi.org/10.3389/fmicb.2016.00384
Wang S, Yang Y, Zhao Y, Zhao H, Bai J, Chen J, Zhou Y, Wang C, Li Y. Sub-MIC Tylosin Inhibits Streptococcus suis Biofilm Formation and Results in Differential Protein Expression. Front Microbiol. 2016 Mar 30;7:384. doi: 10.3389/fmicb.2016.00384. eCollection 2016. PMID: 27065957; PMCID: PMC4811924.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2016 Mar 30;7:384. doi: 10.3389/fmicb.2016.00384. eCollection 2016.

Sub-MIC Tylosin Inhibits Streptococcus suis Biofilm Formation and Results in Differential Protein Expression.

Frontiers in microbiology

Shuai Wang, Yanbei Yang, Yulin Zhao, Honghai Zhao, Jingwen Bai, Jianqing Chen, Yonghui Zhou, Chang Wang, Yanhua Li

Affiliations

  1. Department of Veterinary Pharmacy, College of Veterinary Medicine, Northeast Agricultural University Harbin, China.
  2. Department of Biotechnology, Heilongjiang Vocational College for Nationalities Harbin, China.

PMID: 27065957 PMCID: PMC4811924 DOI: 10.3389/fmicb.2016.00384

Abstract

Streptococcus suis (S.suis) is an important zoonotic pathogen that causes severe diseases in humans and pigs. Biofilms of S. suis can induce persistent infections that are difficult to treat. In this study, the effect of tylosin on biofilm formation of S. suis was investigated. 1/2 minimal inhibitory concentration (MIC) and 1/4 MIC of tylosin were shown to inhibit S. suis biofilm formation in vitro. By using the iTRAQ strategy, we compared the protein expression profiles of S. suis grown with sub-MIC tylosin treatment and with no treatment. A total of 1501 proteins were identified by iTRAQ. Ninety-six differentially expressed proteins were identified (Ratio > ±1.5, p < 0.05). Several metabolism proteins (such as phosphoglycerate kinase) and surface proteins (such as ABC transporter proteins) were found to be involved in biofilm formation. Our results indicated that S. suis metabolic regulation, cell surface proteins, and virulence proteins appear to be of importance in biofilm growth with sub-MIC tylosin treatment. Thus, our data revealed the rough regulation of biofilm formation that may provide a foundation for future research into mechanisms and targets.

Keywords: S. suis; biofilms; iTRAQ; proteomics; tylosin

References

  1. J Antimicrob Chemother. 2007 Aug;60(2):417-20 - PubMed
  2. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2512-7 - PubMed
  3. J Bacteriol. 2011 Feb;193(3):679-85 - PubMed
  4. J Biol Chem. 2012 Feb 3;287(6):4260-74 - PubMed
  5. FEMS Microbiol Lett. 2011 Mar;316(1):36-43 - PubMed
  6. J Proteome Res. 2009 Apr;8(4):1797-809 - PubMed
  7. Ethn Dis. 2010 Winter;20(1 Suppl 1):S1-7-11 - PubMed
  8. Mol Microbiol. 1999 Dec;34(5):1018-28 - PubMed
  9. Future Microbiol. 2010 Mar;5(3):371-91 - PubMed
  10. Antimicrob Agents Chemother. 1990 Mar;34(3):390-3 - PubMed
  11. Infect Immun. 2011 Oct;79(10):4193-200 - PubMed
  12. Microbiology. 2001 Feb;147(Pt 2):431-8 - PubMed
  13. J Antimicrob Chemother. 1998 Feb;41(2):155-61 - PubMed
  14. J Bacteriol. 2013 Jun;195(12 ):2747-54 - PubMed
  15. Microbiol Mol Biol Rev. 2000 Dec;64(4):847-67 - PubMed
  16. Genome Biol. 2003;4(6):219 - PubMed
  17. J Bacteriol. 2002 Feb;184(4):1140-54 - PubMed
  18. Berl Munch Tierarztl Wochenschr. 2007 May-Jun;120(5-6):207-9 - PubMed
  19. Appl Environ Microbiol. 2005 Feb;71(2):979-86 - PubMed
  20. J Bacteriol. 1994 Apr;176(8):2137-42 - PubMed
  21. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2971-5 - PubMed
  22. J Proteome Res. 2011 Aug 5;10(8):3399-417 - PubMed
  23. Proteomics. 2008 Sep;8(17):3506-15 - PubMed
  24. Proteomics. 2007 Dec;7(24):4468-76 - PubMed
  25. Infect Immun. 2001 Apr;69(4):2309-17 - PubMed
  26. PLoS One. 2012;7(3):e33320 - PubMed
  27. Zoonoses Public Health. 2007;54(6-7):253-9 - PubMed
  28. J Proteome Res. 2008 Sep;7(9):4132-42 - PubMed
  29. Int J Antimicrob Agents. 2008 Dec;32(6):481-4 - PubMed
  30. Antimicrob Agents Chemother. 2000 Dec;44(12):3357-63 - PubMed
  31. PLoS Med. 2006 May;3(5):e187 - PubMed
  32. PLoS One. 2012;7(4):e33371 - PubMed
  33. Nat Protoc. 2010 Sep;5(9):1574-82 - PubMed
  34. Infect Immun. 2008 Nov;76(11):5049-61 - PubMed
  35. PLoS Genet. 2011 Feb;7(2):e1001314 - PubMed
  36. Anim Health Res Rev. 2007 Jun;8(1):29-45 - PubMed
  37. Nat Methods. 2009 May;6(5):359-62 - PubMed
  38. Proteomics. 2010 Sep;10(17):3130-41 - PubMed
  39. MBio. 2015 Jul 07;6(4):e00581 - PubMed
  40. Nat Rev Drug Discov. 2013 Oct;12(10):791-808 - PubMed
  41. Cell Biochem Biophys. 2014 Sep;70(1):391-8 - PubMed
  42. Antimicrob Agents Chemother. 1993 Apr;37(4):921-3 - PubMed
  43. PLoS One. 2014 Sep 04;9(9):e107015 - PubMed
  44. Vet Microbiol. 2004 Aug 19;102(1-2):87-94 - PubMed
  45. Arch Microbiol. 2015 Dec;197(10):1173-80 - PubMed
  46. Adv Dent Res. 1997 Apr;11(1):160-7 - PubMed
  47. J Proteomics. 2015 Feb 26;116:1-14 - PubMed
  48. Indian J Med Microbiol. 2006 Jan;24(1):25-9 - PubMed
  49. Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Mar;27(3):185-91 - PubMed

Publication Types